Skip to main content
. 2008 Apr 28;9(2):69–82. doi: 10.1120/jacmp.v9i2.2794

Table 5.

Patients sorted in descending order by absolute value of the difference between cord D5 obtained by using lung, heart, cord (LHC) for deformation and total lung D5 value obtained by using lung, heart, cord, external contour (LHCE) for lung deformation

Patient Cord D5 difference (cGy) Tumor site Disease stage Prescription dose and fractionation scheme Hypofx?
5
500
NSCLC LUL T1N2M0 63 Gy, 35 fractions No
9 500 NSCLC RUL T1N2M1 60 Gy, 30 fractions No
3
150
Adenocarcinoma, distal esophagus T3N1M0 50.4 Gy, 28 fractions No
10 150 Squamous mid‐esophagus T3N1M0 50.4 Gy, 28 fractions No
2
50
NSCLC RLL (post surgery) T2M2N0 50.4 Gy, 28 fractions No
4 50 NSCLC RUL T1N0M0 70 Gy, 35 fractions No
8 0 Adenocarcinoma RUL T1N1M0 recurrent 63 Gy, 30 fractions No
7 0 Squamous cell carcinoma RLL T2N2M0 63 Gy, 35 fractions No
6 0 NSCLC LUL T1N0M0 50 Gy, 4 fractions Yes
1 0 NSCLC left lung T3N2M1 60 Gy, 20 fractions No

D5=maximumdosereceivedbyatleast5%ofspinalcord; Hypofx=hypofractionated; NSCLC=nonsmallcelllungcancer; LUL=leftupperlobe; RUL=rightupperlobe; RLL=rightlowerlobe.